Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc. Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Spark Capital on the deal. Spark Capital led the $115 million Series B financing of Afresh, an AI-powered fresh food technology provider that...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Carbon Biosciences on the deal. Carbon Biosciences, a developer of novel parvovirus-derived gene therapies, announced its emergence from stealth mode and the closing of...
You must be a Standard 1 Year member to access this content.
